Moreover, an intake of angiotensin-converting-enzyme (ACE) inhibitors by patients suffering from renal insufficiency was linked to the development of severe hyperkalemia, which in turn promotes the development of cardiac arrhythmias due to cardiac-myocyte depolarization [21,22,23]. The gene discussed is ACE; the disease is cardiac rhythm disease.